Effectiveness and safety of a new cryotherapy vest to reduce core temperature in athletes (healthy volunteers) after aerobic activity: Crossover Randomized Trial

Centro Universitário São Camilo0 个研究点开始时间: 2020年2月3日最近更新: 2023年5月29日

适应症

试验速览

暂无简介。

•Participants of either sex aged greater than 18 years but less than 60 years; Professional or semi-professional athletes practicing physical activity at least 2x / week for more than 6 months; Signed informed consent; Completion of modified physical activity readiness (Par-Q) and global physical activity fitness (GPAQ) questionnaires; Able to use a treadmill.

•Present with signs or symptoms of acute or chronic illness; Athletes with an initial core temperature less than 35.5 or greater than 37.5 °C; BMI greater than 30 kg/m2; Skin lesions evident or reported by athletes or medical staff that contraindicate participation in the study, such as purulent skin gangrene; Known joint and/or muscle injuries that contraindicate the use of a treadmill; Have contraindications to cryotherapy such as cryoglobulinemia, cold intolerance, Raynaud's disease, hypothyroidism, acute respiratory system disorder, cardiovascular disease (unstable angina or CHF class III and IV), sympathetic nervous system neuropathy, local blood flow disorders, and cachexia; Current participation in another ongoing clinical trial.

发起方

Centro Universitário São Camilo